Today Pfizer/BioNTech announced that their data on the three-dose Covid-19 vaccine for children ages 6 months to under age 5 years had favorable results regarding immune response with minimal side effects.
Today Pfizer/BioNTech announced that their data on the three-dose Covid-19 vaccine for children ages 6 months to under age 5 years had favorable results regarding immune response with minimal side effects.